Diabetic Macular Edema (DME)

Basic Information

Diabetic macular edema (DME) is an accumulation of fluid in the macula resulting from leaking blood vessels. DME is a manifestation of diabetic retinopathy, which causes damage to retinal vessels and vision impairment.

(from AERI web site Nov 2020)

Market Information

Driven by rising rates of diabetes, the number of cases of diabetic retinopathy in the United States is expected to nearly double by 2050, rising from 7.7 million to 14.6 million.1 Approximately half of all people with diabetic retinopathy will develop DME.2

(from AERI web site Nov 2020)

1. Data on file. 2. National Eye Institute. Diabetic Retinopathy. National Institutes of Health. https://nei.nih.gov/eyedata/diabetic. Accessed January 9, 2018. 3. National Eye Institute. Facts About Diabetic Eye Disease. National Institutes of Health. https://nei.nih.gov/health/diabetic/retinopathy. Accessed January 9, 2018.

Currently Approved Drugs 

Image 1 


Image 2 


Current Catalysts in AMP Databases

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon